Cargando…

A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments

Purpose: This study aims to describe a 12-month medication adherence with oral anticancer medications (OAMs) in a routine care medication adherence program, and to better characterize non-persistence. Patients and methods:In this observational, one-centered, longitudinal study, medication adherence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Marie Paule, Achtari Jeanneret, Leila, Chevaux, Bernard, Backes, Claudine, Wagner, Anna Dorothea, Bugnon, Olivier, Luthi, François, Locatelli, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361826/ https://www.ncbi.nlm.nih.gov/pubmed/30761009 http://dx.doi.org/10.3389/fphar.2018.01567

Ejemplares similares

Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study
por: Bourdin, Aline, et al.
Publicado: (2021)

Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes
por: Bawab, Noura, et al.
Publicado: (2023)

Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?
por: Perraudin, Clemence, et al.
Publicado: (2019)

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data
por: Bandiera, Carole, et al.
Publicado: (2021)

Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results
por: Lelubre, Mélanie, et al.
Publicado: (2018)

Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy
por: Lelubre, Mélanie, et al.
Publicado: (2018)

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
por: Kamal, Susan, et al.
Publicado: (2017)

Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
por: Kardas, Przemysław, et al.
Publicado: (2022)

Current Situation of Medication Adherence in Hypertension
por: Vrijens, Bernard, et al.
Publicado: (2017)

The Role of Adherence Thresholds for Development and Performance Aspects of a Prediction Model for Direct Oral Anticoagulation Adherence
por: Ruff, Carmen, et al.
Publicado: (2019)

Menthol: An underestimated anticancer agent
por: Zhao, Yijia, et al.
Publicado: (2023)

Anticancer Evaluation of Adiantum venustum Don
por: Viral, D, et al.
Publicado: (2011)

Selective Acetogenins and Their Potential as Anticancer Agents
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2019)

Gold Compounds and the Anticancer Immune Response
por: Zhou, Ling, et al.
Publicado: (2021)

Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022)

A Review of Auraptene as an Anticancer Agent
por: Tayarani-Najaran, Zahra, et al.
Publicado: (2021)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Biosynthesis of anticancer phytochemical compounds and their chemistry
por: Dogra, Amandeep, et al.
Publicado: (2023)

Identification of target groups and individuals for adherence interventions using tree-based prediction models
por: Wendl, Johannes, et al.
Publicado: (2022)

Digital Medication Adherence Support: Could Healthcare Providers Recommend Mobile Health Apps?
por: Backes, Claudine, et al.
Publicado: (2021)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

Searching Synergistic Dose Combinations for Anticancer Drugs
por: Yin, Zuojing, et al.
Publicado: (2018)

Next-Generation Immunotherapies to Improve Anticancer Immunity
por: Shi, Yaoyao, et al.
Publicado: (2021)

Anticancer effects of licochalcones: A review of the mechanisms
por: Deng, Nan, et al.
Publicado: (2023)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

The need for better AD animal models
por: Medina, Miguel, et al.
Publicado: (2014)

Editorial: Prenatal Beginnings for Better Health
por: Kim, Edward, et al.
Publicado: (2018)

Oral anticancer agent medication adherence by outpatients
por: KIMURA, MICHIO, et al.
Publicado: (2014)

Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH(2)) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury
por: Wyss, Jean-Christophe, et al.
Publicado: (2019)

Is There a Threshold for Medication Adherence? Lessons Learnt From Electronic Monitoring of Drug Adherence
por: Burnier, Michel
Publicado: (2019)

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
por: Ramer, Robert, et al.
Publicado: (2019)

Formononetin: A Review of Its Anticancer Potentials and Mechanisms
por: Tay, Kai-Ching, et al.
Publicado: (2019)

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
por: Fu, Li, et al.
Publicado: (2020)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

MicroRNA as an Important Target for Anticancer Drug Development
por: Fu, Zhiwen, et al.
Publicado: (2021)

Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer
por: Bevinakoppamath, Supriya, et al.
Publicado: (2021)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
por: Lu, Enzhou, et al.
Publicado: (2022)

Acrocomia aculeata associated with doxorubicin: cardioprotection and anticancer activity
por: Monteiro-Alfredo, Tamaeh, et al.
Publicado: (2023)

Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring
por: Forni Ogna, Valentina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5u2srdq6ovvv4sbj6icmi2e0ij